Study of different titanosilicate (TS-1 and ETS-10) as fillers for Mixed Matrix Membranes for CO2/CH4 gas separation applications

Three titanosilicate zeolites were used as fillers for Mixed Matrix Membranes: (i) ETS-10, TS-1 having Si/Ti=100 and (iii) TS-1 using Si/Ti=25. Zeolite samples were characterized by X-Ray Diffraction, Scanning Electron Microscopy, Atomic Emission Spectroscopy, X-Ray Photoelectron Spectroscopy, and CO2 and CH4 adsorption isotherms. TS-1 particles showed a narrow size distribution ranging from 200 nm to 400 nm. In the case of ETS-10, the size distribution was broader ranging from 400 nm to 800 nm. Mixed Matrix Membranes were prepared using Matrimid (R) polyimide as continuous phase and filler loadings of 10, 20, and 30 wt%. Membranes were characterized by Thermogravimetric Analysis, Differential Scanning Calorimetry, and Scanning Electron Microscopy. The performances was measured at 8 bars of transmembrane pressure for CO2/CH4 mixed gases system at 50/50 vol/vol. concentration. Membranes using TS-1 (Si/Ti=25) as filler showed a maximum increase of 89.1% of CO2 permeability and 23.9% increase in separation factor. In the case of TS-1 (Si/Ti=100) only permeability increased significantly, with a maximum increase of 90.1%. Regarding the ETS-10 membranes, both permeability and separation factor increased slightly with respect to the reference polymeric membrane (22.5% in CO2 permeability and 7.8% in the separation factor). In conclusion, TS-1 (Si/Ti=25) is the most suitable filler for the use in Mixed Matrix Membranes for gas separation applications among the titanosilicate studied in this work

Dynamic response of ultrathin highly dense ZIF-8 nanofilms

Ultrathin ZIF-8 nanofilms are prepared by facile step-by-step dip coating. A critical withdrawal speed allows for films with a very uniform minimum thickness. The high refractive index of the films denotes the absence of mesopores. The dynamic response of the films to CO2 exposure resembles behaviour observed for nonequilibrium organic polymers

Enhancement of CO2/CH4 separation performances of 6FDA-based co-polyimides mixed matrix membranes embedded with UiO-66 nanoparticles

Metal-organic frameworks (MOFs) incorporation into mixed matrix membranes (MMMs) is gaining more attention due to the combined advantages of high separation performance and easy processability. Nanoparticles (NPs) of CO2-philic MOF UiO-66 (Zr-BDC) were synthesized with high surface area and ca. 50 nm particle size (and also for comparison with 100 and 200 nm sizes). They were incorporated into three 6FDA-based co-polyimides (namely 6FDA-BisP, 6FDA-ODA, and 6FDA-DAM), forming MMMs with loadings in the 4–23 wt% range. The NPs and MMMs were characterized accordingly by XRD, BET, SEM, TEM, FTIR, and TGA. CO2 and CH4 isotherms on the NPs were measured by a static volumetric method at the pressure up to 10 bar. Fractional free volume (FFV) was calculated using solid density, measured by pycnometer. Gas separation performance was evaluated using a feed composition of 50%:50% CO2:CH4 binary mixture at 35 °C and a pressure difference of 2 bar. The presence of UiO-66 NPs in the continuous 6FDA-BisP and 6FDA-ODA co-polyimides improved both CO2 permeability and CO2/CH4 selectivity by 50–180% and 70–220%, respectively. In the case of 6FDA-DAM MMMs, the CO2 permeability was significantly improved by 92%, while maintaining the CO2/CH4 selectivity. The best results in terms of CO2/CH4 selectivity were 41.9 for 6FDA-BisP (17 wt% filler loading, 108 Barrer of CO2), 57.0 for 6FDA-ODA (7 wt% filler loading, 43.3 Barrer of CO2) and 32.0 for 6FDA-DAM (8 wt% filler loading, 1728 Barrer of CO2)

Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome

Atypical hemolytic uremic syndrome (aHUS) is caused by alternative complement pathway dysregulation, leading to systemic thrombotic microangiopathy (TMA) and severe end-organ damage. Based on 2 prospective studies in mostly adults and retrospective data in children, eculizumab, a terminal complement inhibitor, is approved for aHUS treatment. Here we prospectively evaluated efficacy and safety of weight-based dosing of eculizumab in eligible pediatric patients with aHUS in an open-label phase II study. The primary end point was complete TMA response by 26 weeks. Twenty-two patients (aged 5 months-17 years) were treated; 16 were newly diagnosed, 12 had no prior plasma exchange/infusion during current TMA symptomatology, 11 received baseline dialysis, and 2 had prior renal transplants. By week 26, 14 achieved a complete TMA response, 18 achieved hematologic normalization, and 16 had 25% or better improvement in serum creatinine. Plasma exchange/infusion was discontinued in all, and 9 of the 11 patients who required dialysis at baseline discontinued, whereas none initiated new dialysis. Eculizumab was well tolerated; no deaths or meningococcal infections occurred. Bone marrow failure, wrist fracture, and acute respiratory failure were reported as unrelated severe adverse events. Thus, our findings establish the efficacy and safety of eculizumab for pediatric patients with aHUS and are consistent with proposed immediate eculizumab initiation following diagnosis in children

High-pressure CO2/CH4 separation of Zr-MOFs based mixed matrix membranes

The gas separation properties of 6FDA-DAM mixed matrix membranes (MMMs) with three types of zirconium-based metal organic framework nanoparticles (MOF NPs, ca. 40 nm) have been investigated up to 20 bar. Both NPs preparation and MMMs development were presented in an earlier publication that reported outstanding CO2/CH4 separation performances (50:50 vol% CO2/CH4 feed at 2 bar pressure difference, 35 °C) and this subsequent study is to demonstrate its usefulness to the natural gas separation application. In the current work, CO2/CH4 separation has been investigated at high pressure (2–20 bar feed pressure) with different CO2 content in the feed (10–50 vol%) in the temperature range 35–55 °C. Moreover, the plasticization, competitive sorption effects, and separation of the acid gas hydrogen sulfide (H2S) have been investigated in a ternary feed mixture of CO2:H2S:CH4 (vol% ratio of 30:5:65) at 20 bar and 35 °C. The incorporation of the Zr-MOFs in 6FDA-DAM enhances both CO2 permeability and CO2/CH4 selectivity of this polymer. These MMMs exhibit high stability under separation conditions relevant to an actual natural gas sweetening process. The presence of H2S does not induce plasticization but increases the total acid gas permeability, acid gas/CH4 selectivity and only causes reversible competitive sorption. The overall study suggests a large potential for 6FDA-DAM Zr-MOF MMMs to be applied in natural gas sweetening, with good performance and stability under the relevant process conditions

Active target TPC for study of photonuclear reactions at astrophysical energies

A setup designed to study photonuclear reactions at astrophysical energies - an active target Time Projection Chamber was developed and constructed at the Faculty of Physics, University of Warsaw. The device was successfully employed in two experiments at the Institute of Nuclear Physics Polish Academy of Sciences in Cracow, in which {\gamma}- and neutron-induced reactions with CO2 gas target were measured. The reaction products were detected and their momenta reconstructed. Preliminary results are shown.Comment: Presented at Zakopane Conference on Nuclear Physics 202

Global Variation of Nutritional Status in Children Undergoing Chronic Peritoneal Dialysis : A Longitudinal Study of the International Pediatric Peritoneal Dialysis Network

While children approaching end-stage kidney disease (ESKD) are considered at risk of uremic anorexia and underweight they are also exposed to the global obesity epidemic. We sought to investigate the variation of nutritional status in children undergoing chronic peritoneal dialysis (CPD) around the globe. The distribution and course of body mass index (BMI) standard deviation score over time was examined prospectively in 1001 children and adolescents from 35 countries starting CPD who were followed in the International Pediatric PD Network (IPPN) Registry. The overall prevalence of underweight, and overweight/obesity at start of CPD was 8.9% and 19.7%, respectively. Underweight was most prevalent in South and Southeast Asia (20%), Central Europe (16.7%) and Turkey (15.2%), whereas overweight and obesity were most common in the Middle East (40%) and the US (33%). BMI SDS at PD initiation was associated positively with current eGFR and gastrostomy feeding prior to PD start. Over the course of PD BMI SDS tended to increase on CPD in underweight and normal weight children, whereas it decreased in initially overweight patients. In infancy, mortality risk was amplified by obesity, whereas in older children mortality was markedly increased in association with underweight. Both underweight and overweight are prevalent in pediatric ESKD, with the prevalence varying across the globe. Late dialysis start is associated with underweight, while enteral feeding can lead to obesity. Nutritional abnormalities tend to attenuate with time on dialysis. Mortality risk appears increased with obesity in infants and with underweight in older children.Peer reviewe